Amgen (AMGN) Sees Intra-Day Pressure
- Wall Street drops as banks, health stocks weigh
- BAT Reaches Deal to Acquire Reynolds American (RAI) for $49 Billion
- Morgan Stanley (MS) Tops Q4 EPS by 17c
- Trump, Brexit uncertainty hit stocks and dollar, gold jumps
- Pre-Open Stock Movers 01/17: (FWP) (CLSN) (GEVO) Higher; (ADHD) (CBK) (UEC) Lower (more...)
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
Amgen (NASDAQ: AMGN) sees intra-day pressure. Shares down 0.8%/
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amgen's (AMGN) Fight Over Copies of Biotech Drugs Gets High Court Review - Bloomberg
- Gevo (GEVO) Says EPA Approves Pathway for Isobutanol as an Advanced Biofuel
- Reynolds American (RAI) option volatility flat into BAT agrees to buy for $49.4B
Create E-mail Alert Related CategoriesTrader Talk
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!